Managers

VC-backed Bolt taps Schatzman as CEO

Redwood City, California-based Bolt Biotherapeutics, a biotech firm focused on treating cancer, has named Dr. Randall Schatzman as CEO and a member of the board of directors. Previously, he was CEO of Alder BioPharmaceuticals Inc. Bolt's backers included Novo Holdings, Pivotal bioVenture Partners, Vivo Capital and Nan Fung Life Sciences.

United Kingdom sees the bulk of European VC activity in H1

The tranformation of venture capital forges a new role for GPs

The past decade brought unprecedented change to venture capital. Today’s GP must bring together the sometimes competing goals of specialization, diversification and capitalization

Xiang He Capital racks up $425 mln for fund

Xiang He Capital, a TMT-focused venture firm in China, has closed its second US-denominated fund at a hard cap of $425 million, beating its $350 million target. The fund's limited partners include global consultants, university endowments, foundations, family offices, pensions and fund-of-funds.

DSG Consumer Partners collects $65 mln for third fund

DSG Consumer Partners has raised $65 million for its third fund, according to an SEC filing. Based in Mauritius and Singapore, DSG invests in consumer companies in India and Southeast Asia.

Greenwave Opportunity Fund targets $250 mln

Greenwave Opportunity Fund is seeking to raise $250 million. The fund will invest in, acquire and develop clean energy projects focusing on real estate, energy and water applications.

New firm Safar targets early tech from Harvard, MIT and UR

Ex-Lionsgate exec plans venture firm focused on massive gaming biz

Fundraising cools at end of summer for emerging managers

Coefficient, F2 and Cultivation lead the way in last two weeks in August.

Quansight Futures launches $20 mln early-stage fund

Quansight Futures has launched Quansight Initiate, an early-stage investment fund. The target is $20 million. The fund will invest in startups that leverage open-source technologies.